World Pfizer vaccine raises 'no specific safety concerns': US regulator Data from 38,000 trial participants involved in testing the Pfizer-BioNTech Covid-19 vaccine revealed "no specific safety concerns," Published December 8, 2020 Updated December 8, 2020 07:09pm Save Saved 1 min comment Comments By AFP Add BRecorder as a trusted source on Google WASHINGTON: Data from 38,000 trial participants involved in testing the Pfizer-BioNTech Covid-19 vaccine revealed "no specific safety concerns," a document issued by the US Food and Drug Administration (FDA) said Tuesday. Pfizer Food and Drug Administration Comments Comments are closed for this article. More Stories Shopkeepers and small traders: FBR set to launch new scheme Buying observed at PSX, benchmark index up 1,000 points Oil falls as Lebanon and Israel agree on a ceasefire Gold rises on softer dollar, oil as markets weigh US-Iran peace optimism Dollar clings to 2-month high as Gulf hostilities flare, yen wobbles near intervention zone Israel, Lebanon agree to implement ceasefire, boosting hopes for Iran deal Hormuz situation: Ministry joins FBR, Customs for mulling strategic measures ‘Coalition partners taken on board’: Aurangzeb hints at presenting budget on 10th Three Qatari, one spot LNG cargoes secured July-May trade deficit widens 17.48pc to USD34.76bn YoY Electricity laws: NA panel approves 2 amendments sans debate Browse all stories
Comments
Comments are closed for this article.